Insider

Teva began trading ordinary shares on NYSE and closed its ADS program

On September 14, 2026, Teva Pharmaceutical Industries Ltd began trading ordinary shares on the New York Stock Exchange under ticker TEVA, replacing American depositary shares (ADS) on a one-to-one basis

Verified against 4 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
a long hallway with pictures on the walls
Photo by zhang shuaizhang on Unsplash
101%
Repurchase premium

Key points

  • The company started trading ordinary shares on NYSE and ended its ADS program, exchanging each ADS for one ordinary share
  • Investors now buy and sell ordinary shares directly, rather than depositary units, simplifying ownership and potentially boosting liquidity
  • If a change of control occurs, the company must repurchase the notes at 101% of their principal amount, which could increase cash outlays

What happened

The company started trading ordinary shares on NYSE and ended its ADS program, exchanging each ADS for one ordinary share

At the same time, ordinary shares continue to trade on the Tel Aviv Stock Exchange under the same ticker TEVA

Why it matters

Investors now buy and sell ordinary shares directly, rather than depositary units, simplifying ownership and potentially boosting liquidity

Risks and unknowns

If a change of control occurs, the company must repurchase the notes at 101% of their principal amount, which could increase cash outlays

The note agreements limit the ability to create liens, undertake sale-leaseback transactions and merge, consolidate, sell, lease or transfer assets, which may restrict financial flexibility

What to watch

Watch the upcoming insider trading reports – they will show whether company executives continue selling shares

Also monitor whether net proceeds from note issuances are transferred by subsidiaries to parent Teva, which can be seen in financial statements

Original sources

  1. 8-K filing, September 14, 2026September 14, 2026SHA-256 of our archived copy 043e15e4af2d…
  2. 8-K filing, September 16, 2026September 16, 2026SHA-256 of our archived copy bfd1e5618b5b…
  3. 8-K EX-5.1 filing, September 16, 2026September 16, 2026SHA-256 of our archived copy 9be9c558765b…
  4. 4 filing, September 22, 2026September 22, 2026SHA-256 of our archived copy 06415208faef…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards